Business news from Ukraine

ALL FAMILY DOCTORS IN UKRAINE TO BE VACCINATED AGAINST COVID-19

16 March , 2021  

All family doctors will be vaccinated against COVID-19 through vaccination rooms, which will open from next week, Health Minister Maksym Stepanov said.
“Next week we will open vaccination rooms. All family doctors will be vaccinated against COVID-19 through these rooms,” he said on the Freedom of Speech (Svoboda Slova) program on ICTV on Tuesday night.
According to the national vaccination plan, at least nine mobile vaccination teams per region should work now, but these plans are not being implemented in the field, Stepanov said.
“Local authorities were supposed to reach not 10,000, but more than 12,000-14,000 vaccinations per day. The mobile team did not come here, they did not vaccinate there – this is how they deploy in the field,” he said.
Nevertheless, Stepanov said that in the coming days the rate of vaccination will accelerate and will reach more than 10,000 vaccinations per day.
“Today there was a rather tough conversation, including with some heads of regions,” he said.
Stepanov also said that 1.5 million doses of AstraZeneca (Covishield) vaccine should be delivered to Ukraine by March 31. The Ministry of Health expects permission for their export from the Government of India.
As reported, the first batch of 500,000 doses of Oxford/AstraZeneca (Covishield) vaccine was delivered to Ukraine on the morning of February 23.
Oxford/AstraZeneca is produced at the facilities of the Serum Institute (India) and has the local (trade) name Covishield. It was registered for emergency use in Ukraine on Monday, February 22.
In addition, Ukraine received confirmation of deliveries of 2.2-3.7 million doses of Oxford/AstraZeneca vaccines under COVAX mechanism in the first-second quarter of 2021. In addition, this vaccine will be purchased directly from the manufacturers for public funds.
Ukraine has also signed additional direct contracts for the supply of vaccines against COVID-19, developed with the participation of AstraZeneca (UK-Sweden) and NovaVax (USA) and manufactured at the facilities of the Serum Institute (India).

, ,